Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
about
When is hub gene selection better than standard meta-analysis?A breast cancer prognostic signature predicts clinical outcomes in multiple tumor typesThe microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cellsA smoking-associated 7-gene signature for lung cancer diagnosis and prognosisMultiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosisHybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse predictionDesign and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasisMolecular biology of lung cancer: clinical implicationsIntegrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumorsA genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogenemultiClust: An R-package for Identifying Biologically Relevant Clusters in Cancer Transcriptome ProfilesPredictive biomarkers in precision medicine and drug development against lung cancerRadiomics: the process and the challengesEvolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genesProteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancerAssessment, origin, and implementation of breath volatile cancer markers.SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung CancerSirtuins in metabolism, DNA repair and cancerThe expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumorsInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaThe expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohortsIs there clinical value to prognostic signatures in early-stage NSCLC?Novel image markers for non-small cell lung cancer classification and survival predictionYin Yang gene expression ratio signature for lung cancer prognosisCombining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based studyLung Cancer Gene Signatures and Clinical PerspectivesA novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLCGrowth of lung cancer cells in three-dimensional microenvironments reveals key features of tumor malignancyA novel network model identified a 13-gene lung cancer prognostic signatureInter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair researchEpidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinomaOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPrognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancerGene expression-based classification of non-small cell lung carcinomas and survival predictionKernelized partial least squares for feature reduction and classification of gene microarray dataNetwork-based identification of biomarkers coexpressed with multiple pathwaysDLC1 is the principal biologically-relevant down-regulated DLC family member in several cancersSurvival prediction based on compound covariate under Cox proportional hazard modelsSIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism
P2860
Q21133557-2F6683AC-7096-4009-8023-BC7E4D625BD0Q23909227-A67D2AF9-58E9-4FFE-B249-BD69B8A6806EQ23909716-68337F2D-157B-450B-8B0A-F9C4028D3B04Q23918749-BBBA0282-735A-40FC-945E-E74C42A1D194Q23918758-D8DF9D0C-8763-4897-9E8C-2AB21DB3E63DQ23924046-D6848A00-2F66-4D15-AFDF-A8B94B9DDCD6Q24289207-567869A1-44E1-4BEC-AF27-301D6AFDFE37Q24310644-5C9C0DA7-9917-4876-8011-97A91F415A7AQ24610335-C13A7FD1-40B5-45C0-A62E-5FA7193D58FFQ24614112-1B221AF9-E40D-4573-9763-A814D01F67BFQ24647664-D7004428-6611-497B-9D3D-E8CA8A03986DQ26744071-C28E9E29-A21B-4EE8-9F80-4DCD8C6B66D5Q26824536-4ADEC4AB-216F-47F1-B3FE-7D238CC44A9EQ26865378-E07B3CE8-670B-4809-B22C-E968988035D7Q27025625-0714E99A-9519-4593-A85B-075E77244991Q27307731-4C9F1F5D-3F6F-4712-A549-2E92990C709EQ27692565-9A94268C-2A5A-47E8-8517-6B42FE8E9BB5Q27853293-DE77B404-9929-4E00-A345-60F8639797C3Q28070892-C64529D3-770D-47D5-A344-5817C898C80AQ28289698-B0687AFA-7493-4DE5-9317-DBFF07D416B2Q28303718-1578CE4E-1E3A-432A-ADC4-CAF4E42AFE13Q28383695-950A2A71-53B2-41FE-AEC1-C6B4569BE083Q28384571-23E59A15-D6D2-4399-8992-CF5E39DB6793Q28385611-7DBD53F0-F925-4F65-B387-6053DC6A2900Q28385778-D30C7792-A2F0-4D38-BA4F-C956F15BB097Q28386520-A9C13069-782F-44EC-8BE1-7A6388297104Q28387769-F3BBA87F-E66B-47B6-91D7-20C96DA713CBQ28387995-3E12D1D3-04F4-44D9-9E03-2624584A003EQ28388539-5FDEA4C5-642B-4D4F-AB34-F7B71072F8DCQ28388627-58BB4607-BF3E-46EA-9393-6E163ED07C3AQ28388726-972F5A3A-2F27-4357-ACDE-94437C58A9F5Q28388842-5A63CECA-18B5-44C2-86F4-C7FA7DB7C7DCQ28393146-03A4106B-FCFC-4865-932C-0DE6723C998BQ28394974-456C84FE-A682-4B95-9DEC-0414993FE6DCQ28395058-EC9A8B58-5B7E-46D0-9961-F67EC5E69131Q28396969-1432AB7B-CF82-44D4-8424-D4B2A597803AQ28397059-33448F29-7290-4680-95B2-4BB1001C6164Q28397799-4B40F4EB-CDA9-45D2-ADB1-60878944F86BQ28484571-5A11B98F-D9DD-46A9-93F6-FD152A2AEDF5Q28587694-8DA0ED5F-09BB-4649-A999-45A0861647DF
P2860
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Gene expression-based survival ...... site, blinded validation study
@en
Gene expression-based survival ...... ite, blinded validation study.
@ast
Gene expression-based survival ...... ite, blinded validation study.
@nl
type
label
Gene expression-based survival ...... site, blinded validation study
@en
Gene expression-based survival ...... ite, blinded validation study.
@ast
Gene expression-based survival ...... ite, blinded validation study.
@nl
prefLabel
Gene expression-based survival ...... site, blinded validation study
@en
Gene expression-based survival ...... ite, blinded validation study.
@ast
Gene expression-based survival ...... ite, blinded validation study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Gene expression-based survival ...... ite, blinded validation study.
@en
P2093
Agnes Viale
Anupama Sharma
Barbara Conley
Barbara Weir
Chang Qi Zhu
Christine Ladd-Acosta
Daniel Strumpf
David E Misek
David G Beer
Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma
P2860
P2888
P304
P356
10.1038/NM.1790
P407
P50
P577
2008-07-20T00:00:00Z
P5875
P6179
1040467803